Literature DB >> 21788971

Bone: reference bone turnover markers-just a fairy tale?

Markus J Seibel.   

Abstract

Mesh：

Year:  2011        PMID： 21788971     DOI： 10.1038/nrendo.2011.121

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Interlaboratory variation of biochemical markers of bone turnover.

Authors:  M J Seibel; M Lang; W J Geilenkeuser
Journal:  Clin Chem       Date:  2001-08       Impact factor: 8.327

2.  Evaluation of a new commercial IRMA for bone-specific alkaline phosphatase during treatment with hormone replacement therapy and calcitonin.

Authors:  K Overgaard; P Alexandersen; B J Riis; C Christiansen
Journal:  Clin Chem       Date:  1996-06       Impact factor: 8.327

3.  Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study.

Authors:  P L van Daele; M J Seibel; H Burger; A Hofman; D E Grobbee; J P van Leeuwen; J C Birkenhäger; H A Pols
Journal:  BMJ       Date:  1996-02-24

4.  Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study.

Authors:  Christian Meier; Tuan V Nguyen; Jacqueline R Center; Markus J Seibel; John A Eisman
Journal:  J Bone Miner Res       Date:  2004-12-06       Impact factor: 6.741

5.  Bone turnover markers and prediction of fracture: a prospective follow-up study of 1040 elderly women for a mean of 9 years.

Authors:  Kaisa K Ivaska; Paul Gerdhem; H Kalervo Väänänen; Kristina Akesson; Karl J Obrant
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

6.  Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial.

Authors:  Douglas C Bauer; Dennis M Black; Patrick Garnero; Marc Hochberg; Susan Ott; John Orloff; Desmond E Thompson; Susan K Ewing; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2004-05-24       Impact factor: 6.741

7.  Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.

Authors:  Rosemary A Hannon; Jackie A Clowes; Alison C Eagleton; Amna Al Hadari; Richard Eastell; Aubrey Blumsohn
Journal:  Bone       Date:  2004-01       Impact factor: 4.398

8.  The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.

Authors:  Pierre J Meunier; Christian Roux; Ego Seeman; Sergio Ortolani; Janusz E Badurski; Tim D Spector; Jorge Cannata; Adam Balogh; Ernst-Martin Lemmel; Stig Pors-Nielsen; René Rizzoli; Harry K Genant; Jean-Yves Reginster
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

9.  Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk.

Authors:  Somnath Sarkar; Jean-Yves Reginster; Gerald G Crans; Adolfo Diez-Perez; Karen V Pinette; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2003-12-22       Impact factor: 6.741

10.  International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.

Authors:  Samuel Vasikaran; Cyrus Cooper; Richard Eastell; Andrea Griesmacher; Howard A Morris; Tommaso Trenti; John A Kanis
Journal:  Clin Chem Lab Med       Date:  2011-05-24       Impact factor: 3.694
  10 in total
  1 in total

1.  Biochemical markers in the follow-up of the osteoporotic patients.

Authors:  Alessandro Terreni; Paola Pezzati
Journal:  Clin Cases Miner Bone Metab       Date:  2012-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.